109 related articles for article (PubMed ID: 28972492)
1. AGE-RELATED SPECIFICITIES OF ENDOMETRIAL PROLIFERATION/STEM CELL INDEX DISTRIBUTION.
Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
Georgian Med News; 2017 Sep; (270):99-104. PubMed ID: 28972492
[TBL] [Abstract][Full Text] [Related]
2. SPECIFICITIES OF ENDOMETRIAL PROLIFERATION/STEM CELL INDEX DISTRIBUTION IN ENDOMETRIOID CARCINOMA OF DIFFERENT GRADE OF MALIGNANCY.
Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
Georgian Med News; 2018 Mar; (276):117-123. PubMed ID: 29697394
[TBL] [Abstract][Full Text] [Related]
3. PROLIFERATIVE/STEM CELL INDEX AND PHENOTYPIC CHARACTERISTICS OF PROLIFERATIVE PROCESSES IN ENDOMETRIUM.
Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
Georgian Med News; 2018 Sep; (282):156-161. PubMed ID: 30358561
[TBL] [Abstract][Full Text] [Related]
4. Expression of a putative stem cell marker Musashi-1 in endometrium.
Lu X; Lin F; Fang H; Yang X; Qin L
Histol Histopathol; 2011 Sep; 26(9):1127-33. PubMed ID: 21751144
[TBL] [Abstract][Full Text] [Related]
5. Influence of menopause on the cell kinetics of normal, hyperplastic, and malignant endometrium.
Ishihara H; Itamochi H
Gynecol Obstet Invest; 1995; 40(2):129-32. PubMed ID: 8575691
[TBL] [Abstract][Full Text] [Related]
6. [Proliferative activity of normal endometrial cells, endometrial hyperplasia cells and endometrial cancer cells using the monoclonal antibody to PCNA].
Hareyama H
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1427-1. PubMed ID: 7705752
[TBL] [Abstract][Full Text] [Related]
7. Endometrial eosinophilic syncytial change related to breakdown: immunohistochemical evidence suggests a regressive process.
Shah SS; Mazur MT
Int J Gynecol Pathol; 2008 Oct; 27(4):534-8. PubMed ID: 18753967
[TBL] [Abstract][Full Text] [Related]
8. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin identifies human endometrial epithelial progenitor cells by in vitro stem cell assays.
Nguyen HPT; Xiao L; Deane JA; Tan KS; Cousins FL; Masuda H; Sprung CN; Rosamilia A; Gargett CE
Hum Reprod; 2017 Nov; 32(11):2254-2268. PubMed ID: 29040564
[TBL] [Abstract][Full Text] [Related]
10. [An analysis on the clinicopathological characteristics of 79 cases atypical endometrial hyperplasia].
Wang ZQ; Yang XQ; Wang JL; Xie JL; Shen DH; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):19-23. PubMed ID: 21429429
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific somatic stem-cell isolation and characterization from human endometriosis. Key roles in the initiation of endometrial proliferative disorders.
Heidari-Keshel S; Rezaei-Tavirani M; Ai J; Soleimani M; Baradaran-Rafii A; Ebrahimi M; Roozafzoon R; Rahmanzadeh S; Raeisossadati R; Omidi R; Ghanbari Z
Minerva Med; 2015 Apr; 106(2):95-108. PubMed ID: 25517500
[TBL] [Abstract][Full Text] [Related]
12. Simple hyperplasia of the endometrium: an evaluation of proliferative activity by Ki-67 immunostaining.
Ambros RA
Int J Gynecol Pathol; 2000 Jul; 19(3):206-11. PubMed ID: 10907167
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
15. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical pattern of protein P21, cyclin D1 and cyclin E in endometrial hyperplasia.
Brucka A; Bartczak P; Ratyńska M; Sporny S
Pol J Pathol; 2009; 60(1):19-25. PubMed ID: 19670700
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium.
Shevra CR; Ghosh A; Kumar M
J Postgrad Med; 2015; 61(1):15-20. PubMed ID: 25511212
[TBL] [Abstract][Full Text] [Related]
18. The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia.
Bese T; Vural A; Ozturk M; Dagistanli F; Demirkiran F; Tuncdemir M; Arvas M; Sanioglu C; Kosebay D
Int J Gynecol Cancer; 2006; 16(2):809-13. PubMed ID: 16681766
[TBL] [Abstract][Full Text] [Related]
19. Proliferative and apoptotic changes in the healthy canine endometrium and in cystic endometrial hyperplasia.
Reusche N; Beineke A; Urhausen C; Beyerbach M; Schmicke M; Kramer S; Günzel-Apel AR
Theriogenology; 2018 Jul; 114():14-24. PubMed ID: 29574305
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
